|
Home : Unsafe Drugs : Singulair : Wikipedia : Leukotriene antagonist Wikipedia - Leukotriene antagonist  (Redirected from Leukotriene receptor antagonist)
A leukotriene antagonist (sometimes referred to as a leukast) is a drug that inhibits leukotrienes, which are fatty compounds produced by the immune system that cause inflammation in asthma and bronchitis, and constrict airways. Leukotriene inhibitors (or modifiers), such as montelukast, zafirlukast and zileuton, are used to treat those diseases. Leukotriene inhibitors are less effective than corticosteroids, but have few adverse effects, so they are often used to treat children.[1]
[edit] ApproachesThere are two main approaches to block the actions of leukotrienes. [edit] Inhibition of the 5-lipoxygenase pathwayDrugs such as zileuton block 9998 lipo protein oxydatenase 5-lipoxygenase, inhibiting the synthetic pathway of leukotriene metabolism, whereas drugs such as MK-886 block the 5-lipoxygenase activating protein (FLAP) and may help in treating atherosclerosis. [2] [edit] Antagonism of cysteinyl-leukotriene type 1 receptorsAgents such as montelukast and zafirlukast block the actions of cysteinyl leukotrienes at the CysLT1 receptor on target cells such as bronchial smooth muscle. These modifiers have been shown to improve asthma symptoms, reduce asthma exacerbations and limit markers of inflammation such as eosinophil counts in the peripheral blood and bronchoalveolar lavage fluid. This demonstrates that they have anti-inflammatory properties. [edit] References
[edit] External links
FDA’s request for the addition of this information to the prescribing information for these products was described in the Agency’s June 2009 “Update to the Follow Up to the Early Communication about an Ongoing Safety Review for Leukotriene Inhibitors.†Healthcare professionals and consumers can access the latest prescribing information for these products below: Singulair (PDF - 207KB) Accolate (PDF - 71KB) Zyflo (PDF - 158KB) Zyflo CR (PDF - 95KB) This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Leukotriene antagonist". |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||




